Infections in patients with multiple sclerosis treating with disease-modifying therapies: a risk assessment cohort study

被引：0
|
作者：
Fattahi, M. R. [1 ]
Sahraian, M. A. [1 ]
Mesgarof, M. A. [1 ]
Valizadeh, A. [1 ]
Azimi, A. [1 ]
Moghadasi, A. N. [1 ]
Doosti, R. [1 ]
Hemmati, Z. [2 ]
Abouzari, F. [3 ]
Ghashti, S. Hamtaei [1 ]
机构：
[1] Univ Tehran Med Sci, Neurol, Tehran, Iran
[2] Univ Tehran Med Sci, Nursing & Midwifery Care, Tehran, Iran
[3] Univ Tehran Med Sci, Psychol, Tehran, Iran
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1092
引用
收藏
页码：866 / 867
页数：2
相关论文
共 50 条
  • [1] Multiple Sclerosis, Disease-Modifying Therapies, and Infections
    Langer-Gould, Annette M.
    Smith, Jessica B.
    Gonzales, Edlin G.
    Piehl, Fredrik
    Li, Bonnie H.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2023, 10 (06):
  • [2] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Grebenciucova, Elena
    Pruitt, Amy
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (11)
  • [3] Infections in Patients Receiving Multiple Sclerosis Disease-Modifying Therapies
    Elena Grebenciucova
    Amy Pruitt
    Current Neurology and Neuroscience Reports, 2017, 17
  • [4] Outpatient infections, multiple sclerosis and disease-modifying therapies
    Langer-Gould, A.
    Smith, J. B.
    Piehl, F.
    Li, B. H.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 635 - 636
  • [5] Assessment and management of infectious risk in multiple sclerosis patients treated with disease-modifying therapies
    Zingaropoli, Maria Antonella
    Pasculli, Patrizia
    Iannetta, Marco
    Perri, Valentina
    Tartaglia, Matteo
    Crisafulli, Sebastiano Giuseppe
    Merluzzo, Chiara
    Baione, Viola
    Mazzocchi, Lorenzo
    Taglietti, Ambra
    Pauri, Flavia
    Frontoni, Marco
    Altieri, Marta
    Gaeta, Aurelia
    Antonelli, Guido
    Conte, Antonella
    Mastroianni, Claudio
    Ciardi, Maria Rosa
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429
  • [6] Assessing the risk of multiple sclerosis disease-modifying therapies
    Ayrignac, Xavier
    Bilodeau, Philippe-Antoine
    Prat, Alexandre
    Girard, Marc
    Labauge, Pierre
    Le Lorier, Jacques
    Larochelle, Catherine
    Duquette, Pierre
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (07) : 695 - 706
  • [7] Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying Therapies
    Balshi, Alexandra
    Leuenberger, Grace
    Dempsey, John
    Manning, Nova
    Baber, Ursela
    Sloane, Jacob A.
    NEUROLOGY-CLINICAL PRACTICE, 2025, 15 (02)
  • [8] Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort
    Melesse, Dessalegn Y.
    Marrie, Ruth Ann
    Blanchard, James F.
    Yu, Bo Nancy
    Evans, Charity
    PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1093 - 1101
  • [9] Disease-modifying therapies for multiple sclerosis
    De Angelis, Floriana
    John, Nevin A.
    Brownlee, Wallace J.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [10] Multiple sclerosis and disease-modifying therapies
    Minen, Mia T.
    Karceski, Steven
    NEUROLOGY, 2011, 77 (04) : E26 - E26
12345